Naltrexone depot (DrugAbuse Sciences)
Related Experiment Video
Updated: Sep 25, 2026

A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training
Published on: January 29, 2017
1Alcohol Research Center, Department of Psychiatry, University of Connecticut Health Center, Farmington, CT 06030, USA. modesto@psychiatry.uchc.edu
Abstract:
DrugAbuse Sciences is developing naltrexone depot, a sustained-release (SR) injectable formulation of naltrexone for the potential treatment of alcoholism and opiate addiction. This formulation was developed to help alcoholics and heroin addicts overcome the problems with compliance experienced with the daily-administered tablet form of naltrexone [322165]. Phase III trials of naltrexone depot for the treatment of alcoholics and phase II trials of naltrexone depot for injectable suspension (Naltrel) for the treatment of opiate addiction are ongoing [426301].
Related Concept Videos
Oral Drug Delivery Systems: Continuous-Release Systems
Transdermal Drug Delivery Systems
Drug Dependence
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Abuse and Addiction: Pharmacological Phenomena
Modified-Release Drug Delivery Systems: Overview

